What Are Tom Frinzi’s Plans after J&J Acquires AMO? Frinzi Talks J&J, Symfony, and Much More Artwork

OIS Podcast | Ophthalmology's leading Podcast

Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.

All Episodes

OIS Podcast | Ophthalmology's leading Podcast

What Are Tom Frinzi’s Plans after J&J Acquires AMO? Frinzi Talks J&J, Symfony, and Much More

November 22, 2016 • OIS

This has been a busy year for Thomas Frinzi, senior vice president of Abbott’s vision business. He took the helm of Abbott Medical Optics in January. In July, the FDA approved the company’s promising new Tecnis Symfony IOL. Then Johnson & Johnson agreed to pay $4 billion to acquire the vision device company in September. What’s next?